Graves’ orbitopathy occurs sex-independently in an autoimmune hyperthyroid mouse model-Reference-Cited by-同舟云学术

Graves’ orbitopathy occurs sex-independently in an autoimmune hyperthyroid mouse model

Published:2018-08-30 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Schlüter Anke,Flögel Ulrich,Diaz-Cano Salvador^ORCID,Görtz Gina-Eva,Stähr Kerstin,Oeverhaus Michael,Plöhn Svenja,Mattheis Stefan,Moeller Lars C.,Lang Stephan,Bechrakis Nikolaos E.,Banga J. Paul,Eckstein Anja,Berchner-Pfannschmidt Utta

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-31253-4.pdf

Reference54 articles.

1. Smith, T. J. & Hegedus, L. Graves’ Disease. The New England journal of medicine 375, 1552–1565, https://doi.org/10.1056/NEJMra1510030 (2016).

2. Bahn, R. S. Graves’ ophthalmopathy. The New England journal of medicine 362, 726–738, https://doi.org/10.1056/NEJMra0905750 (2010).

3. Salvi, M., Berchner-Pfannschmidt, U. & Ludgate, M. In Graves’ orbitopathy. A Multidisciplinary Approach - Qestions and Answers. Vol. 3rd edition (eds Wiersinga, W. M. & Kahaly, G. J.) 41–60 (Karger, 2017).

4. Campi, I., Vannucchi, G. & Salvi, M. Therapy of Endocrine Disease: Endocrine dilemma: management of Graves’ orbitopathy. European journal of endocrinology/European Federation of Endocrine Societies 175, R117–133, https://doi.org/10.1530/EJE-15-1164 (2016).

5. Smith, T. J. et al. Teprotumumab for Thyroid-Associated Ophthalmopathy. The New England journal of medicine 376, 1748–1761, https://doi.org/10.1056/NEJMoa1614949 (2017).

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of ibrutinib on inflammation in a mouse model of Graves’ orbitopathy;Frontiers in Endocrinology;2024-08-30

2. Cre-loxP System-Based Mouse Model for Investigating Graves' Disease and Associated Orbitopathy;Thyroid®;2023-11-01

3. Graves’ Orbitopathy Models: Valuable Tools for Exploring Pathogenesis and Treatment;Hormone and Metabolic Research;2023-10-30

4. Potential involvement of the bone marrow in experimental Graves’ disease and thyroid eye disease;Frontiers in Endocrinology;2023-09-22

5. Linsitinib, an IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye disease;Frontiers in Endocrinology;2023-06-26